<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03459456</url>
  </required_header>
  <id_info>
    <org_study_id>H41632</org_study_id>
    <nct_id>NCT03459456</nct_id>
  </id_info>
  <brief_title>Measuring Automated Behavioral Observations &amp; Vocal Expressions (ABOVE)</brief_title>
  <acronym>ABOVE</acronym>
  <official_title>Measuring Automated Behavioral Observations &amp; Vocal Expressions (ABOVE) While Recording From the Brain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Baylor College of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose to synchronize automated measurements of behavior - head, body, and&#xD;
      face dynamics, gaze, and vocal prosody - with simultaneous recordings of brain activity in&#xD;
      clinically relevant contexts.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Baylor College of Medicine (BCM), University of Pittsburgh (UPitt) and Brown University will&#xD;
      collaborate on this research project. BCM will be the only site that will enroll study&#xD;
      subjects and perform study assessments. UPitt and Brown will supervise data management,&#xD;
      measurement and modeling of multimodal signals and collaborate on research design and machine&#xD;
      learning.&#xD;
&#xD;
      Following initial screening, subjects will participate in one testing session lasting about 2&#xD;
      hours. The addition of these preliminary studies will allow investigators to obtain&#xD;
      information in order to differentiate and code OCD-distress versus social anxiety and&#xD;
      identify rituals related to OCD.&#xD;
&#xD;
      Research Material, Data, and Information to be collected:&#xD;
&#xD;
      Interviews, rating scales, video, audio, behavioral assessments, and heart rate will be&#xD;
      obtained.&#xD;
&#xD;
      Preliminary Testing in Un-implanted Subjects: Automated Behavioral Measures of OCD-related&#xD;
      Distress (i.e., obsessions and urge to ritualize) and Overt Rituals:&#xD;
&#xD;
      The Provocation OC task (Provoc) and the Trier Social Stress Test (TSST) will be used to&#xD;
      evoke OC-related distress and anxiety unrelated to OCD (e.g., performance anxiety),&#xD;
      respectively. These tasks will be preceded by a neutral baseline (the subject may be asked to&#xD;
      describe how they traveled to the clinic to the experimenter) and a positive affect&#xD;
      induction, the Broad-Minded Affective Coping procedure (BMAC) a clinical technique that uses&#xD;
      recalled positive autobiographical memories and mental imagery to elicit positive affect.&#xD;
      Because anxiety and negative affect may have carryover effects, neutral baseline and BMAC&#xD;
      will be presented prior to the non-OCD and OCD distress inductions. In the BMAC, subjects&#xD;
      will be instructed to recall and describe a recent positive memory/experience. The order of&#xD;
      Provoc and TSST will be counterbalanced across the subjects. Use of a conveyor belt may be&#xD;
      used during the Provoc tasks to present the evoking stimuli. Simultaneously recorded measures&#xD;
      are noted in the Table attached in Section S and include: AFAR, new suite of behavioral&#xD;
      measures (shown as shaded), hand/arm movements and heart rate.&#xD;
&#xD;
      A third provocation task will be added to elicit overt rituals (e.g., handwashing) in the&#xD;
      clinic. It will occur following the BMAC and TSST/Provoc tasks and a relaxation break.&#xD;
&#xD;
      Subjects will be asked to wash their hands at a sink in our clinic inside an exam room where&#xD;
      their behaviors will be recorded using hardware-synchronized cameras: one, to capture frontal&#xD;
      view of the face for AFAR; and another, to record full body movement for CPM. The&#xD;
      investigators are aware of only one prior study of automated coding of compulsive behavior.&#xD;
      In that study, a computer vision approach was able to discriminate subjects with OCD from&#xD;
      healthy subjects on the basis of handwashing videos in which regions of interest (ROIs) were&#xD;
      defined for objects (e.g., soap dispenser) used for handwashing. The investigators will&#xD;
      combine this ROI paradigm with a CPM approach that captures hand and body movements. Dropouts&#xD;
      from the ritual paradigm will be replaced.&#xD;
&#xD;
      These same tasks will also be performed on up to 4 subjects that have consented to receive a&#xD;
      DBS implant on a separate protocol. Informed consent will also be collected from these&#xD;
      implanted subjects for the purpose of completing the tasks described above on this study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 11, 2018</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in brain activity</measure>
    <time_frame>baseline to Hour 2</time_frame>
    <description>measured before, during and after PROVOC task, Trier Social Stress Test (TSST) and exposure task</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Heart Rate</measure>
    <time_frame>baseline to Hour 2</time_frame>
    <description>measured before, during and after PROVOC task, Trier Social Stress Test (TSST) and exposure task</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">27</enrollment>
  <condition>OCD</condition>
  <condition>Obsessive-Compulsive Disorder</condition>
  <arm_group>
    <arm_group_label>OCD subjects</arm_group_label>
    <description>Subjects meeting inclusion/exclusion criteria with OCD will be exposed to the following:&#xD;
Provocation OC task (Provoc)&#xD;
Trier Social Stress Test (TSST)&#xD;
Exposure provocation task</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control subjects</arm_group_label>
    <description>Subjects meeting inclusion/exclusion criteria without OCD (age and gender matched with OCD subjects) will be exposed to the following:&#xD;
Provocation OC task (Provoc)&#xD;
Trier Social Stress Test (TSST)&#xD;
Exposure provocation task</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Provocation OC task (Provoc)</intervention_name>
    <description>used to evoke OC-related distress</description>
    <arm_group_label>Control subjects</arm_group_label>
    <arm_group_label>OCD subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Trier Social Stress Test (TSST)</intervention_name>
    <description>used to evoke anxiety unrelated to OCD (e.g., performance anxiety)</description>
    <arm_group_label>Control subjects</arm_group_label>
    <arm_group_label>OCD subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exposure provocation task</intervention_name>
    <description>used to elicit overt OCD rituals</description>
    <arm_group_label>Control subjects</arm_group_label>
    <arm_group_label>OCD subjects</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The primary source of OCD subjects will be self-referrals generated through BCM&#xD;
        Clinicaltrials website, Clinicaltrials.gov, and BCM Psychiatry Clinic. The investigators&#xD;
        also anticipate referrals from local area clinicians in addition to affiliate entities.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        OCD subjects:&#xD;
&#xD;
          -  The subject has a minimum score of â‰¥16 on the Y-BOCS;&#xD;
&#xD;
          -  If applicable, on a stable pharmacologic regimen;&#xD;
&#xD;
          -  Sample will be enriched with OCD subjects having contamination obsessions and&#xD;
             handwashing compulsions, and scores on items 9 and 10 of the Y-BOCS reflecting&#xD;
             difficulty resisting and controlling compulsions;&#xD;
&#xD;
        Healthy Control Subjects:&#xD;
&#xD;
          -  Men and women will be age/gender matched with subjects&#xD;
&#xD;
          -  Absence of any psychiatric disorder determined by the MINI^53 for DSM-5 with the&#xD;
             exception of non-impairing specific phobia.&#xD;
&#xD;
          -  Low scores on measures of contamination concerns and disgust sensitivity based on&#xD;
             Y-BOCS scores below 10 and the Disgust Scale-Revised (total score &lt;8).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        OCD Subjects:&#xD;
&#xD;
          -  Subject has a documented lifetime diagnosis of psychotic disorders such as&#xD;
             schizophrenia;&#xD;
&#xD;
          -  Alcohol or substance abuse/dependence reported within 6 months, excluding nicotine;&#xD;
&#xD;
          -  The subject is deemed at high risk of suicidal behavior or impulsivity. The Beck&#xD;
             Depression Inventory^52 (BDI) will be completed by all subjects and responses reviewed&#xD;
             by a clinician.&#xD;
&#xD;
        Healthy Control Subjects:&#xD;
&#xD;
        - Those not meeting the inclusion criteria described in the inclusion section above.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wayne Goodman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carmen Vasquez</last_name>
    <phone>713-798-4729</phone>
    <email>anav@bcm.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gregory Vogt</last_name>
    <phone>713-798-4729</phone>
    <email>gsvogt@bcm.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Brown University</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clarissa Aguilar</last_name>
      <phone>713-798-3080</phone>
      <email>clarissa.aguilar@bcm.edu</email>
    </contact>
    <contact_backup>
      <last_name>Gregory Vogt</last_name>
      <phone>(713) 798-4729</phone>
      <email>gsvogt@bcm.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Wayne K Goodman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raymond Cho, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nithya Ramakrishnan, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric Storch, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elizabeth McIngvale, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gregory Vogt</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>March 1, 2018</study_first_submitted>
  <study_first_submitted_qc>March 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2018</study_first_posted>
  <last_update_submitted>June 18, 2021</last_update_submitted>
  <last_update_submitted_qc>June 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baylor College of Medicine</investigator_affiliation>
    <investigator_full_name>Wayne Goodman MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>OCD</keyword>
  <keyword>Obsessive-Compulsive Disorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

